Critical Appraisal of Guidelines for Nanoparticles in Developed and Developing Countries

Nanoparticles offer stability and enhanced delivery capacity compared to other drug delivery systems. They facilitate the incorporation of both hydrophilic and hydrophobic compounds and can be administered through various routes, such as enteral, parenteral, oral, and inhalation. Nanotechnology serves as an enabling tool for both incremental and transformative innovations. In the pharmaceutical industry, it holds immense potential by enhancing therapeutic efficacy and reducing toxicity through improved drug delivery mechanisms, such as targeted, sustained, controlled, triggered, or prolonged delivery. This can result in lower drug doses, sustained bioavailability, and minimized side effects and drug resistance. The nanoscale size of nanoparticles imparts distinctive and advantageous properties that enhance their chemical, physical, and biological functionalities compared to larger particles. Numerous biologically important molecules, including water, hemoglobin, proteins, glucose, antibodies, enzymes, and receptors, exist within the nanoscale range, making them highly valuable for medical applications. This gap is often attributed to the nascent stage of nanomedicine and the ambiguity surrounding regulatory frameworks for clinical applications, which hampers its progress. Despite a limited understanding of the pharmacokinetics, pharmacodynamics, and toxicity of various nanomaterials in humans, there are numerous potential advantages associated with these technologies. There remains considerable optimism about the impact of nanomedicine on the pharmaceutical sector however, clear regulatory guidance is urgently needed to provide legal certainty for manufacturers, policymakers, healthcare professionals, and the public. Since the early 2000s, substantial investments have been directed toward the production of nanomaterials due to advancements in nanotechnology. The unique physical and chemical properties of these materials enable a wide array of applications across different fields. The growing incorporation of nanomaterials into medical products is fostering new advancements in healthcare, notably in diagnostics and therapeutics, and offering approaches to address previously unresolved medical challenges.